These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 16973090)

  • 1. Breast cancer (non-metastatic).
    Rodger A; Stebbing J; Thompson AM
    Clin Evid; 2006 Jun; (15):2360-92. PubMed ID: 16973090
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer (non-metastatic).
    Dixon JM; Rodger A; Stebbing J
    Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer (non-metastatic).
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2003 Jun; (9):1940-70. PubMed ID: 12967459
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant endocrine treatment in primary breast cancer - review of literature.
    Mathew J; Asgeirsson KS; Jackson LR; Cheung KL; Robertson JF
    Breast; 2009 Dec; 18(6):339-44. PubMed ID: 19836953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ; Dixon JM
    Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Zammit C; Yelland A; Deutsch G
    Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
    [No Abstract]   [Full Text] [Related]  

  • 8. [Slow progress in therapy of breast carcinoma].
    Aumiller J
    MMW Fortschr Med; 2004 Jan; 146(3-4):4-6, 8, 10. PubMed ID: 15035437
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
    Pritchard KI
    J Clin Oncol; 2005 Aug; 23(22):4850-2. PubMed ID: 16009956
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Future endocrine therapy of breast cancer].
    Ejlertsen B
    Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breast carcinoma in accessory gland: a case report].
    Sivelli R; Del Rio P; Arcuri MF; Corcione L
    G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 14. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W
    MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer (non-metastatic).
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2004 Jun; (11):2300-33. PubMed ID: 15652112
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK; Kamby C; Nielsen DL
    Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of chemotherapy depending on hormone status in breast cancer].
    Ito Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():568-71. PubMed ID: 17679212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.